No Data
No Data
Will Trinity Biotech Stock Gain From Its Latest Patent Process?
Trinity Biotech Provides An Update On The Continued Development Of Its Continuous Glucose Monitor Technology; Says Recent Testing Of This Patented Process Has Confirmed Its Effectiveness In Improving The Performance Of Trinity Biotech's Glucose Biosensor
Express News | Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology
Trinity Biotech Releases 2023 Annual Report
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Trinity Biotech Welcomes New Chief Commercial Officer